Jaguar Health Says Napo Unit Providing Crofelemer Oral Solution For Compassionate Use In Infant With Intestinal Failure From Congenital Sodium Diarrhea; Plans Mid-2027 NDA Filing For Crofelemer In MVID
Share
Why It Matters
Jaguar Health is helping a sick baby get a special medicine while they test it more. This shows the medicine might work for rare diseases, and the company plans to ask the government for official approval by mid-2027.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.